Bone Marrow Stromal Damage after Chemo/Radiotherapy: Occurrence, Consequences and Possibilities of Treatment

References

• Weiss L. The hematopoietic microenvironment of the bone marrow: an ultrastructural study of the stroma in rats. Anat Rec 1976; 186: 161–184
   PubMedGoogle Scholar
• Dexter T. M., Allen T. D., Lajtha L. G. Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol 1977; 91: 335–344
   PubMed Web of Science ®Google Scholar
• Lichtman M. A. The ultrastructure of the hemopoietic environment of the marrow: a review. Exp Hematol 1981; 9: 391–410
   PubMed Web of Science ®Google Scholar
• Tavassoli M., Friedenstein A. Hemopoietic stromal microenvironment. Am J of Hematol 1983; 15: 195–203
   PubMed Web of Science ®Google Scholar
• Friedenstein A. J., Chailakhyan R. K., Latsinik N. V., Panasyuk A. F., Keiliss-Borok I. V. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 1974; 17: 331–340
   PubMed Web of Science ®Google Scholar
• Dexter T. M., Spooncer E., Simmons P., Allen T. D. Long-term marrow culture: an overview of techniques and experience. Kroc Found Ser 1984; 18: 57–96
   PubMedGoogle Scholar
• Strobel E. S., Gay R. E., Greenberg P. L. Characterization of the in vitro stromal microenvironment of human bone marrow. Int J Cell Cloning 1986; 4: 341–356
   PubMedGoogle Scholar
• Charbord P., Gown A. M., Keating A., Singer J. W. CGA-7 and HHF, two monoclonal antibodies that recognize muscle actin and react with adherent cells in human long-term bone marrow cultures. Blood 1985; 66: 1138–1142
   PubMed Web of Science ®Google Scholar
• Owen M. Marrow stromal stem cells. J. Cell Sci. 1988; 10: 63–76
   Google Scholar
• Beresford J. N. Osteogenic stem cells and the stromal system of bone and marrow. Clin Orthop 1989; 270–280
   PubMed Web of Science ®Google Scholar
• Friedenstein A. J. Osteogenic stem cells in the bone marrow. Bone Miner Res. 1990; 7: 243–272
   Google Scholar
• Allen T. D., Dexter T. M., Simmons P. J. Marrow biology and stem cells. Immunol Ser 1990; 49: 1–38
   PubMedGoogle Scholar
• Dexter T. M. Stromal cell associated haemopoiesis. J Cell Physiol Suppl 1982; 1: 87–94
   PubMedGoogle Scholar
• Caplan A. I. Mesenchymal stem cell. J. Orthop. Res. 1991; 9: 641–650
   PubMed Web of Science ®Google Scholar
• Beresford J. N., Bennett J. H., Devlin C., Leboy P. S., Owen M. E. Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J Cell Sci 1992; 102: 341–351
   PubMed Web of Science ®Google Scholar
• Krebsbach P. H., Kuznetsov S. A., Satomura K., Emmons R. V., Rowe D. W., Robey P. G. Bone formation in vivo: comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation 1997; 63: 1059–1069
   PubMed Web of Science ®Google Scholar
• Martin I., Muraglia A., Campanile G., Cancedda R., Quarto R. Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology 1997; 138: 4456–4462
   PubMed Web of Science ®Google Scholar
• Johnstone B., Bering T. M., Caplan A. I., Goldberg V. M., Yoo J. U. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 1998; 238: 265–272
   PubMed Web of Science ®Google Scholar
• Kuznetsov S. A., Krebsbach P. H., Satomura K., Ken J., Riminucci M., Benayahu D., Robey P. G. Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J Bone Miner Res 1997; 12: 1335–1347
   PubMed Web of Science ®Google Scholar
• Dennis J. E., Merriam A., AwadaUah A., Yoo J. U., Johnstone B., Caplan A. I. A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse. J Bone Miner Res 1999; 14: 700–709
   PubMed Web of Science ®Google Scholar
• Gerasimov U. V., Friedenstein A. J., Chailakhyan R. K., Shishkova V. V. [Differentiation potentials of clonal strains of bone marrow fibroblasts]. Biull Eksp Biol Med 1986; 101: 717–719
   PubMedGoogle Scholar
• Ohgushi H., Goldberg V. M., Caplan A. I. Repair of bone defects with marrow cells and porous ceramic. Experiments in rat. Acta Orthop. Scand. 1989; 60: 334–339
   PubMed Web of Science ®Google Scholar
• Goshima J., Golberg V. M., Caplan A. I. The osteogenic potential of cultured-expanded rat marrow mesenchymal cells assayed in vivo in calcium phosphate ceramic blocks. Clin. Orthop. 1991; 262: 298–311
   PubMed Web of Science ®Google Scholar
• Gundle R., Joyner C. J., Triffitt J. T. Human bone tissue formation in diffusion chamber culture in vivo by bone derived cells and marrow stromal fibroblastic cells. Bone 1995; 16: 597–601
   PubMed Web of Science ®Google Scholar
• Quarto R., Thomas D., Liang C. T. Bone progenitor cell deficits and the age-associated decline in bone repair capacity. Calcif Tissue Int 1995; 56: 123–129
   PubMed Web of Science ®Google Scholar
• Pittenger M. P., Mackay A. M., Beck S. C., Jaiswal R. K., Douglas R., Mosca J. D., Moorman M. A., Simonetti D. W., Craig S., Marshak D. R. Multilineage potential of adult human mesenchymal stem cells [In Process Citation]. Science 1999; 284: 143–147
   PubMed Web of Science ®Google Scholar
• Bianco P., Robey P. Diseases of bone and the stromal cell lineage. J Bone Miner Res 1999; 14: 336–341
   PubMed Web of Science ®Google Scholar
• Goldman I. M., Schmitz N., Niethammer D., Gratwohl A. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1998. Accreditation Sub-Cornmittee of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1998; 21: 1–7
   PubMed Web of Science ®Google Scholar
• Barbot C., Rice A., Vanes I., Mahon F. X., Jazwiec B., Reiffers J. Quality and functional capacity of the bone marrow raicroenvironment of autologous blood stem cell transplantation (ABSCT) recipients. Nouv Rev Fr Hematol 1994; 36: 325–331
   PubMedGoogle Scholar
• Carlo-Stella C., Tabilio A., Regazzi E., Garau D., La Tagliata R., Trasarti S., Andrizzi C., Vignetti M., Meloni G. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors. Bone Marrow Transplant 1997; 20: 465–471
   PubMed Web of Science ®Google Scholar
• Del Canizo C., Lopez N., Caballero D., Fernandez E., Brufau A., Vazquez L., Mateos V., Gutierrez N., San Miguel J. F. Haematopoietic damage persists 1 year after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1999; 23: 901–905
   PubMed Web of Science ®Google Scholar
• Domenech J., Gihana E., Dayan A., Truglio D., Linassier C., Desbois I., Lamagnere J. P., Colombat P., Binet C. Haemopoiesis of transplanted patients with autologous marrows assessed by long-term marrow culture, fir. J Haematol 1994; 88: 488–496
   Web of Science ®Google Scholar
• Domenech J., Roingeard F., Herault O., Truglio D., Desbois I., Colombat P., Binet C. Changes in the functional capacity of marrow stromal cells after autologous bone marrow transplantation. Leak Lymphoma 1998; 29: 533–546
   PubMed Web of Science ®Google Scholar
• Radford J. A., Testa N. G., Crowther D. The long-term effects of MVPP chemotherapy for Hodgkin's disease on bone marrow function. Br J Cancer 1990; 62: 127–132
   PubMed Web of Science ®Google Scholar
• Rice A., Reiffers J., Bernard P., Foures C., Bascans E., Lacombe F., Marit G., Broustet A. Incomplete stroma formation after allogeneic marrow or autologous blood stem cell transplantation. Nouv Rev Fr Hematol 1992; 34: 167–174
   PubMedGoogle Scholar
• Testa N. G., Hendry J. H., Molineux G. Long-term bone marrow damage in experimental systems and in patients after radiation or chemotherapy. Anticancer Res 1985; 5: 101–110
   PubMed Web of Science ®Google Scholar
• Galotto M., Berisso G., Delfino L., Podesta M., Ottaggio L., Dallorso S., Dufour C., Ferrara G. B., Abbondandolo A., Dini G., Bacigalupo A., Cancedda R., Quarto R. Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients. Exp Hematol 1999; 27: 1460–1466
   PubMed Web of Science ®Google Scholar
• Patt H. M., Maloney M. A. Bone marrow regeneration after local injury: a review. Exp Hematol 1975; 3: 135–148
   PubMed Web of Science ®Google Scholar
• Fried W., Kedo A., Barone J. Effects of cyclophosphamide and of busulfan on spleen colony-forming units and on hematopoietic stroma. Cancer Res 1977; 37: 1205–1209
   PubMed Web of Science ®Google Scholar
• Fried W., Barone J. Residual marrow damage following therapy with cyclophosphamide. Exp Hematol 1980; 8: 610–614
   PubMed Web of Science ®Google Scholar
• Piersma A. H., Ploemacher R. E., Brockbank K. G. Radiation damage to femoral hemopoietic stroma measured by implant regeneration and quantitation of fibroblastic progenitors. Exp Hematol 1983; 11: 884–890
   PubMed Web of Science ®Google Scholar
• Hendry J. H. The cellular basis of long-term marrow injury after irradiation. Radiother Oncol 1985; 3: 331–338
   PubMed Web of Science ®Google Scholar
• Molineux G., Testa N. G., Massa G., Schofield R. An analysis of haemopoietic and microenvironmental populations of mouse bone marrow after treatment with busulphan. Biomed Pharmacother 1986; 40: 215–220
   PubMed Web of Science ®Google Scholar
• Molineux G., Xu C., Hendry J., Testa N. G. A cellular analysis of long-term haematopoietic damage in mice after repeated treatment with cyclophosphamide. Cancer Chemother Pharmacol 1986; 18: 11–16
   PubMed Web of Science ®Google Scholar
• Greenberger J. S. Toxic effects on the hematopoietic microenvironment. Exp Hematol 1991; 19: 1101–1109
   PubMed Web of Science ®Google Scholar
• Domenech J., Roingeard F., Binet C. The mechanisms involved in the impairment of hematopoiesis after autologous bone marrow transplantation. Leak Lymphoma 1997; 24: 239–256
   PubMed Web of Science ®Google Scholar
• Novitzky N., Mohamed R. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation. Exp Hematol 1995; 23: 1661–1666
   PubMed Web of Science ®Google Scholar
• Soligo D. A., Lambertenghi Deliliers G., Servida F., Quirici N., Campiglio S., Tagliaferri E., Oriani A., Romitti L., Delia Volpe A., Annaloro C. Haematopoietic abnormalities after autologous stem cell transplantation in lymphoma patients. Bone Marrow Transplant 1998; 21: 15–22
   PubMed Web of Science ®Google Scholar
• Del Canizo M., Lopez N., Vazquez L., Fernandez M., Ana B., Caballero M., Amigo M., Mateos M., Gutierrez N., San Migue J. F. Hematopoietic damage prior to PBSCT and its influence on hematopoietic recovery. Haematologica 1999; 84: 511–516
   PubMedGoogle Scholar
• Arnold R., Schmeiser T., Heit W., Frickhofen N., Pabst G., Heimpel H., Kubanek B. Hemopoietic reconstitution after bone marrow transplantation. Exp Hematol 1986; 14: 271–277
   PubMed Web of Science ®Google Scholar
• Ma D. D., Varga D. E., Biggs J. C. Haemopoietic reconstitution after allogeneic bone marrow transplantation in man: recovery of haemopoietic progenitors (CPU-Mix, BFU-E and CFU-GM). Br J Haematol 1987; 65: 5–10
   PubMed Web of Science ®Google Scholar
• Messner H. A., Curtis J. E., Minden M. D., Tritchler D., Lockwood G., Takahashi T., Lepine J., Jamal N., Tweeddale M., Wandl U. Clonogenic hemopoietic precursors in bone marrow transplantation. Blood 1987; 70: 1425–1432
   PubMed Web of Science ®Google Scholar
• Domenech J., Linassier C., Gihana E., Dayan A., Truglio D., Bout M., Petitdidier C., Delain M., Petit A., Bremond J. L., et al. Prolonged impairment of hematopoiesis after high-dose therapy followed by autologous bone marrow transplantation. Blood 1995; 85: 3320–3327
   PubMed Web of Science ®Google Scholar
• Podesta M., Piaggio G., Frassoni F., Pitto A., Mordini N., Bregante S., Valeriani A., Bacigalupo A. Deficient reconstitution of early progenitors after allogeneic bone marrow transplantation. Bone Marrow Transplant 1997; 19: 1011–1017
   PubMed Web of Science ®Google Scholar
• Kelly P. J., Atkinson K., Ward R. L., Sambrook P. N., Biggs J. C., Eisman J. A. Reduced bone mineral density in men and women with allogeneic bone marrow transplantation. Transplantation 1990; 50: 881–883
   PubMed Web of Science ®Google Scholar
• Castaneda S., Carmona L., Carvajal I., Arranz R., Diaz A., Garcia-Vadillo A. Reduction of bone mass in women after bone marrow transplantation. Calcif Tissue Int 1997; 60: 343–347
   PubMed Web of Science ®Google Scholar
• Bhatia S., Ramsay N. K., Weisdorf D., Griffiths H., Robison L. L. Bone mineral density in patients undergoing bone marrow transplantation for myeloid malignancies. Bone Marrow Transplant 1998; 22: 87–90
   PubMed Web of Science ®Google Scholar
• Ebeling P. R., Thomas D. M., Erbas B., Hopper J. L., Szer J., Grigg A. P. Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation. J Bone Miner Res 1999; 14: 342–350
   PubMed Web of Science ®Google Scholar
• Kauppila M., Irjala K., Koskinen P., Pulkki K., Sonninen P., Viikari J., Remes K. Bone mineral density after allogeneic bone marrow transplantation. Bone Marrow Transplant 1999; 24: 885–889
   PubMed Web of Science ®Google Scholar
• Valimaki M. J., Kinnunen K., Volin L., Tahtela R., Loyttyniemi E., Laitinen K., Makela P., Keto P., Ruutu T. A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin. Bone Marrow Transplant 1999; 23: 355–361
   PubMed Web of Science ®Google Scholar
• Nysom K., Holm K., Michaelsen K. R., Hertz H., Jacobsen N., Muller J., Molgaard C. Bone mass after allogeneic BMT for childhood leukaemia or lympboma. Bone Marrow Transplant 2000; 25: 191–196
   PubMed Web of Science ®Google Scholar
• Schulte C., Beelen D. W., Schaefer U. W., Mann K. Bone loss in long-term survivors after transplantation of hematopoietic stem cells: a prospective study. Osteoporos Int 2000; 11: 344–353
   PubMed Web of Science ®Google Scholar
• Schimmer A. D., Minden M. D., Keating A. Osteoporosis after blood and marrow transplantation: clinical aspects. Biol Blood Marrow Transplant 2000; 6: 175–181
   PubMed Web of Science ®Google Scholar
• Weilbaecher K. N. Mechanisms of osteoporosis after hematopoietic cell transplantation. Biol Blood Marrow Transplant 2000; 6: 165–174
   PubMed Web of Science ®Google Scholar
• Ishida T., Inaba M., Hisha H., Sugiura K., Adachi Y., Nagata N., Ogawa R., Good R. A., Ikehara S. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune diseases in MRL/MP-Ipr/Ipr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor. J Immunol 1994; 152: 3119–3127
   PubMed Web of Science ®Google Scholar
• Takeuchi K., Inaba M., Miyashima S., Ogawa R., Ikehara S. A new strategy for treatment of autoimmune diseases in chimeric resistant MRL/lpr mice. Blood 1998; 91: 4616–4623
   PubMed Web of Science ®Google Scholar
• El-Badri N. S., Wang B.Y. Cherry, Good R. A. Osteoblasts promote engraftment of allogeneic hematopoietic stem cells. Exp Hematol 1998; 26: 110–116
   PubMed Web of Science ®Google Scholar
• Klyushnenkova E., Mosca J. D., McIntosh K. R. Human menchymal stem cells suppress allogeneic T cell responses in vitro: implications for allogeneic transplantation. Blood 1998a; 92: 642
   Google Scholar
• Chang J., Coutinho L., Morgenstern G., Scarffe J. H., Deakin D., Harrison C., Testa N. G., Dexter T. M. Reconstitution of haemopoietic system with autologous marrow taken during relapse of acute myeloblastic leukaemia and grown in long-term culture. Lancet 1986; 1: 294–295
   PubMed Web of Science ®Google Scholar
• Bamett M. J., Eaves C. J., Phillips G. L., Kalousek D. K., Klingemann H. G., Lansdorp P. M., Reece D. E., Shepherd J. D., Shaw G. J., Eaves A. C. Successful autografting in chronic myeloid leukaemia after maintenance of marrow in culture. Bone Marrow Transplant 1989; 4: 345–351
   PubMed Web of Science ®Google Scholar
• Lazarus H. M., Haynesworth S. E., Gerson S. L., Rosenthal N. S., Caplan A. I. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant 1995; 16: 557–564
   PubMed Web of Science ®Google Scholar
• Koc O. N., Gerson S. L., Cooper B. W., Dyhouse S. M., Haynesworth S. E., Caplan A. I., Lazarus H. M. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 2000; 18: 307–316
   PubMed Web of Science ®Google Scholar
• Pereira R. F., Halford K. W., O'Hara M. D., Leeper D. B., Sokolov B. P., Pollard M. D., Bagasra O., Prockop D. J. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci USA 1995; 92: 4857–4861
   PubMed Web of Science ®Google Scholar
• Almeida-Porada G., Porada C. D., Tran N., Zanjani E. D. Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation. Blood 2000; 95: 3620–3627
   PubMed Web of Science ®Google Scholar
• Goan S. R., Junghahn I., Wissler M., Becker M., Aumann J., Just U., Martiny-Baron G., Fichtner I., Henschler R. Donor stromal cells from human blood engraft in NOD/SCID mice [In Process Citation]. Blood 2000; 96: 3971–3978
   PubMed Web of Science ®Google Scholar
• Liechty K. W., MacKenzie T. C., Shaaban A. F., Radu A., Moseley A. B., Deans R., Marshak D. R., Flake A. W. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 2000; 6: 1282–1286
   PubMed Web of Science ®Google Scholar
• Anklesaria P., Kase K., Glowacki J., Holland C. A., Sakakeeny M. A., Wright J. A., FitzGerald T. J., Lee C. Y., Greenberger J. S. Engraftment of a clonal bone marrow stromal cell line in vivo stimulates hematopoietic recovery from total body irradiation. Proc Natl Acad Sci USA 1987; 84: 7681–7685
   PubMed Web of Science ®Google Scholar
• Simmons P. J., Przepiorka D., Thomas E. D., Torok-Storb B. Host origin of marrow stromal cells following allogeneic bone marrow transplantation. Nature 1987; 328: 429–432
   PubMed Web of Science ®Google Scholar
• Santucci M. A., Trabetti E., Martinelli G., Buzzi M., Zaccaria A., Pileri S., Farabegoli P., Sabattini E., Tura S., Pignatti P. F. Host origin of bone marrow fibroblasts following allogeneic bone marrow transplantation for chronic myeloid leukemia. Bone Marrow Transplant 1992; 10: 255–259
   PubMed Web of Science ®Google Scholar
• Horwitz E. M., Prockop D. J., Fitzpatrick L. A., Koo W. W., Gordon P. L., Neel M., Sussman M., Orchard P., Marx J. C., Pyeritz R. E., Brenner M. K. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999; 5: 309–313
   PubMed Web of Science ®Google Scholar
• Muraglia A., Cancedda R., Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 2000; 113: 1161–1166
   PubMed Web of Science ®Google Scholar
• Banfi A., Muraglia A., Dozin B., Mastrogiacomo M., Cancedda R., Quarto R. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy. Exp Hematol 2000; 28: 707–715
   PubMed Web of Science ®Google Scholar